ZURICH, Dec. 30, 2024 /PRNewswire/ — Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, announced today it completed the sale of its 50% interest in Bericap North America (BCNA) for $122 million on December 27, with the proceeds used to reduce debt.

Amcor completed the sale of its 50% interest in Bericap North America (BCNA) for $122 million, with the proceeds used to reduce debt. Amcor completed the sale of its 50% interest in Bericap North America (BCNA) for $122 million, with the proceeds used to reduce debt.

Fiscal 2024 total sales for the joint venture were approximately $190 million and adjusted EBIT was approximately $19 million, both of which were previously fully consolidated under Amcor’s Rigid Packaging business. Adjusted net income attributable to Amcor for fiscal 2024 was approximately $8 million. Net of the resulting reduction in interest expense, the transaction is not expected to have an impact on Amcor’s financial outlook for fiscal 2025.  

About Amcor

Amcor is a global leader in developing and producing responsible packaging solutions across a variety of materials for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect products, differentiate brands, and improve supply chains. The Company offers a range of innovative, differentiating flexible and rigid packaging, specialty cartons, closures and services. The company is focused on making packaging that is increasingly recyclable, reusable, lighter weight and made using an increasing amount of recycled content. In fiscal year 2024, 41,000 Amcor people generated $13.6 billion in annual sales from operations that span 212 locations in 40 countries. NYSE: AMCR; ASX: AMC  www.amcor.com I LinkedIn I YouTube

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA

ROCKVILLE, Md. and SUZHOU, China, Jan. 9, 2024 /PRNewswire/ — Innovent Biologics,…

OWNDAYS REVAMPS BRAND IDENTITY, DEBUTING NEW RETAIL DESIGN IN JAPAN AND SINGAPORE THIS JULY

A new reiteration of the brand logo, tagline, retail design and online…

SMARTIES™ Thailand 2025 Announces Winners: Recognising Marketing Excellence and Innovation

BANGKOK, Nov. 4, 2025 /PRNewswire/ — The SMARTIES™ Thailand 2025 Awards honored 58…